| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/12/2005 | US6878705 Especially agents against viruses of the herpes family. |
| 04/12/2005 | US6878703 Mixture with diuretics; hypotensive agents |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878689 Administering D-alanyl-3-(naphthalen-2-yl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide and/or salts, especially the dihydrochloride |
| 04/12/2005 | US6878541 Papilloma pseudo-virus and preparation |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | US6878525 Peptide leukotriene receptor |
| 04/12/2005 | US6878522 Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| 04/12/2005 | US6878371 Isolating autologous bone marrow- mononuclear cells from the subject; and transplanting locally into the tissue an effective amount of the autologous bone-marrow mononuclear cells, resulting in formation of new blood vessels in tissue |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/12/2005 | CA2128380C 4-aryloxy- and 4-arylthiopiperidine derivatives |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005031347A1 Methods |
| 04/07/2005 | WO2005030975A1 METHOD OF PREPARING α-GLYCOSYLISOQUERCITRIN, INTERMEDIATE THEREFOR, AND BY-PRODUCT |
| 04/07/2005 | WO2005030960A1 Staple type oligonucleotide and drug comprising the same |
| 04/07/2005 | WO2005030795A1 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compounds |
| 04/07/2005 | WO2005030773A1 Novel pyrazolopyrimidine derivatives |
| 04/07/2005 | WO2005030760A1 Substituted heteroaryl benzofuran acids |
| 04/07/2005 | WO2005030740A1 Thiazoline derivative and use of the same |
| 04/07/2005 | WO2005030716A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | WO2005030715A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 04/07/2005 | WO2005030333A2 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 04/07/2005 | WO2005030332A2 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 04/07/2005 | WO2005030256A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 04/07/2005 | WO2005030243A1 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| 04/07/2005 | WO2005030242A1 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| 04/07/2005 | WO2005030238A1 Peptides having, for example, an antiangiogenic activity and applications thereof in therapeutics |
| 04/07/2005 | WO2005030235A1 Method of processing ginseng for medicinal use and composition |
| 04/07/2005 | WO2005030234A1 Mulberry leaf extract/ocimum containing composition |
| 04/07/2005 | WO2005030233A1 Active oxygen scavenging agent and process for producing the same |
| 04/07/2005 | WO2005030209A1 Pyridine derivatives and use thereof as urotensin ii antagonists |
| 04/07/2005 | WO2005030207A1 Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome |
| 04/07/2005 | WO2005030202A1 Use of angiotensin ii receptor antagonists for treating cerebrovascular disorders |
| 04/07/2005 | WO2005009428A3 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 04/07/2005 | WO2004108064A3 Diosgenin-based composition suitable for topical application |
| 04/07/2005 | WO2004099394A3 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
| 04/07/2005 | WO2004096206A3 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor |
| 04/07/2005 | WO2004046732A8 Methods for screening compounds modulating cholesterol flux and uses thereof |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004010959A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | WO2003090689A3 Neurodegenerative disorder treatment using gdnf secreting neural cells |
| 04/07/2005 | US20050075516 Anticarcinogenic agents formed by phosphorylation |
| 04/07/2005 | US20050075480 Urotensin-II agonists and antagonists |
| 04/07/2005 | US20050075396 Modulation of type 2 diabetes and drug delivery |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075391 Nitric oxide donor composition and method for treatment of anal disorders |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
| 04/07/2005 | US20050075351 4-(Azaindol-3-yl)-quinazoline, 4-(azaoxindol-3-yl)-quinazoline, or 4-(diazaindol-3-yl)-quinazoline derivatives as glycogen synthase kinase inhibitors; Alzheimer's, Parkinson's, Huntington's disease; Down syndrome, amyotrophic lateral sclerosis; neurodegenerative and brain disorders; cognition activators |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075336 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 04/07/2005 | US20050075335 Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation |
| 04/07/2005 | US20050075334 Novel compounds |
| 04/07/2005 | US20050075329 S-tofisopam, a prodrug or a salt thereof, free of its R enantiomer, and a carrier; may also contain one or more other anticonvulsants |
| 04/07/2005 | US20050075287 Use of erythropoietin for the preventive or curative treatment of cardiac failure |
| 04/07/2005 | US20050075275 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 04/07/2005 | US20050075271 Crystalline beta2 adrenergic receptor agonist |
| 04/07/2005 | US20050075269 Substituted benzofuran-2-carboxamides derivatives |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074762 Nucleotide sequences coding hormone protein for use in prevention and treatment of arteriosclerosis, diabetes, obesity and liver disorders |
| 04/07/2005 | US20050074756 FALP proteins |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050074457 Simplified, high throughput screening for identification of heat shock protein 90 ligands selective for high affinity form |
| 04/07/2005 | US20050074436 Systems and methods for treating patients with processed lipoaspirate cells |
| 04/07/2005 | DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/07/2005 | CA2554982A1 Method of inhibiting remnant lipoprotein production |
| 04/07/2005 | CA2539961A1 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 04/07/2005 | CA2539895A1 Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-n-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compo |
| 04/07/2005 | CA2539512A1 Iloprost in combination therapies for the treatment of pulmonary arterial hypertension |
| 04/07/2005 | CA2538711A1 Substituted heteroaryl benzofuran acids |
| 04/07/2005 | CA2538694A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | CA2538680A1 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| 04/07/2005 | CA2538263A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 04/07/2005 | CA2538215A1 Staple oligonucleotides and medicaments comprising the same |
| 04/07/2005 | CA2506282A1 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 04/06/2005 | EP1520590A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1520021A2 Antisense modulation of lrh1 expression |
| 04/06/2005 | EP1519961A1 Low molecular weight oversulfated polysaccharide |
| 04/06/2005 | EP1519957A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519943A2 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 04/06/2005 | EP1519925A1 Oxazole derivatives and their use as insulin sensitizers |
| 04/06/2005 | EP1519923A1 Novel benzimidazol-2-one derivatives and their use |
| 04/06/2005 | EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors |
| 04/06/2005 | EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 04/06/2005 | EP1519919A1 Indolin phenylsulfonamide derivatives |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519753A1 Pharmaceutical combination of a thromboxane a2 receptor antagonist and a cox-2 inhibitor |